Jennison Associates LLC Coherus Bio Sciences, Inc. Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$8.65 - $16.28 $232,166 - $436,955	-26,840 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$14.45 - $20.25 $4,826 - $6,763	-334 Reduced 1.23%	26,840 $443,000
Q2 2018 Aug 02, 2018	SELL	$10.25 - $17.45 $9,922 - $16,891	-968 Reduced 3.44%	27,174 $380,000
Q1 2018 Apr 20, 2018	BUY	$9.1 - $13.7 $256,092 - $385,545	28,142 New	28,142 $311,000

135

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $108M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.